- Report
- April 2024
- 115 Pages
Global
From €3982EUR$4,500USD£3,412GBP
- Report
- August 2022
- 120 Pages
Global
From €3982EUR$4,500USD£3,412GBP
- Report
- July 2025
- 82 Pages
United States
From €3097EUR$3,500USD£2,654GBP
- Report
- December 2024
- 30 Pages
Global
From €2433EUR$2,750USD£2,085GBP
- Drug Pipelines
- April 2025
- 180 Pages
Global
From €2212EUR$2,500USD£1,896GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1770EUR$2,000USD£1,516GBP
- Report
- December 2024
- 152 Pages
Global
From €3495EUR$3,950USD£2,995GBP
- Report
- December 2024
- 30 Pages
Global
From €2433EUR$2,750USD£2,085GBP
- Report
- December 2024
- 30 Pages
Global
From €2433EUR$2,750USD£2,085GBP
- Report
- July 2024
- 150 Pages
Global
From €3318EUR$3,750USD£2,843GBP
- Report
- June 2024
- 200 Pages
Global
From €7034EUR$7,950USD£6,028GBP
- Report
- May 2025
- 196 Pages
Global
From €4203EUR$4,750USD£3,602GBP
- Report
- April 2023
- 115 Pages
Global
From €4203EUR$4,750USD£3,602GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2468EUR$2,789USD£2,115GBP
- Report
- April 2023
- 160 Pages
Global
From €4379EUR$4,949USD£3,752GBP
- Report
- April 2023
- 116 Pages
Global
From €3982EUR$4,500USD£3,412GBP
- Report
- February 2025
- 135 Pages
Global
From €15922EUR$17,995USD£13,644GBP
- Report
- December 2024
- 70 Pages
Global
From €3535EUR$3,995USD£3,029GBP
- Report
- October 2022
- 81 Pages
Global
From €3092EUR$3,495USD£2,650GBP
- Report
- January 2025
- 105 Pages
Global
From €3500EUR$4,237USD£3,104GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more